Bajaj Healthcare FY26 revenue rises 12.6% to Rs 6,110 million
11 May 2026 //
INDPHARMAPOST
Bajaj Healthcare Posts Q2 FY26 PAT At Rs. 11.10 Cr
22 Oct 2025 //
INDPHARMAPOST
Bajaj Health receives exclusive rights for Magnesium L Threonate
17 Jan 2025 //
INDPHARMAPOST
Bajaj moves Indian patent office to grant compulsory license of Baricitinib
29 Jun 2021 //
INDIAINFOLINE

Market Place
Sourcing Support